Drug Topics

JUNE 7, 2023

The median annual cost for new oncology medicines launched in 2022 was $260,000, up from $63,534 10 years ago, an IQVIA report finds.

464

464

PhRMA

JUNE 7, 2023

The Inflation Reduction Act (IRA) makes significant changes to Part D’s benefit structure and coverage, which will require careful policy development and thoughtful implementation. On Monday, PhRMA submitted comments on the Calendar Year 2025 Part D Redesign changes, outlining key considerations for the Centers for Medicare and Medicaid Services (CMS) to help mitigate against potential disruptions to seniors’ access to medicines through Part D.

259

259

Drug Topics

JUNE 7, 2023

Air quality in New York City was the worst in the world on Tuesday morning.

464

464

PharmaVoice

JUNE 7, 2023

IDEA Pharma’s 12th index finds that Pfizer and AstraZeneca reign supreme again.

162

162

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patient Care

Drug Topics

JUNE 7, 2023

The role of pharmacy benefit managers in the health care space is being scrutinized more than ever before.

462

462

STAT

JUNE 7, 2023

BOSTON — The drug industry has spent the past year speaking against new mechanisms that could limit how much governments or insurers pay for certain new medicines. Robert Califf, the Food and Drug Administration chief, walked on stage Wednesday and told a crowd of biotech leaders that drug costs needed fixing. “We don’t agree,” said Califf, referring to a conversation he had backstage with Ted Love , the new chair of the Biotechnology Innovation Organization.

FDA 145

FDA Insurance 145

Pharmacy Times

JUNE 7, 2023

CCR5 mutation creates a challenge for HIV to infect more cells, thereby creating resistance to the virus.

145

145

STAT

JUNE 7, 2023

An unusually early and ferocious outbreak of forest fires across Canada has sent unprecedented amounts of smoke pollution to regions of the eastern United States unaccustomed to such hazards. Three years after the onset of the Covid-19 pandemic, the ensuing air pollution has once again put respiratory health at the forefront of many North Americans’ minds.

144

144

Pharmacy Times

JUNE 7, 2023

It’s time for pharmacies to take a page out of the books of hospitals and tech companies by expanding and streamlining their use of contingent labor.

Hospitals 132

Hospitals 132

PharmaVoice

JUNE 7, 2023

The chief commercial officer shares how the company “beat the odds” to bring a rare disease drug to market.

130

130

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

Pharmacy Times

JUNE 7, 2023

Having more severe sleep apneas was associated with having lower brain volume in the medial temporal lobe area of the brain, which could suggest loss of brain cells.

123

123

Fierce Pharma

JUNE 7, 2023

Merck has taken the lead, filing a lawsuit seeking to overturn drug pricing measures in the Inflation Reduction Act (IRA). | Merck has filed a lawsuit seeking to overturn drug-pricing measures in the Inflation Reduction Act (IRA). Now, emboldened by the New Jersey drugmaker, other biopharma CEOs are making their concerns known. At the BIO International Convention, Biogen CEO Chris Viehbacher registered severe criticism of the IRA and said his company was considering filing its own lawsuit.

119

119

Pharmacy Times

JUNE 7, 2023

Levels of troponin were higher in people who had type 2 diabetes for a longer period than people with healthy blood levels.

123

123

STAT

JUNE 7, 2023

Wildfires blazing in and around Quebec are creating hazardous health conditions throughout North America. Over 100 million people were under alerts for unhealthy air quality as of Wednesday, and people in the Northeast and Midwest — areas that typically don’t deal with the effects of wildfires — are confronting orange-tinged, hazy skies and newly urgent questions about the harmful effects of air pollution.

115

115

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

Pharmacy Times

JUNE 7, 2023

There may be more than 200 symptoms associated with long COVID-19.

123

123

Fierce Healthcare

JUNE 7, 2023

Years of rising operating profits and cash reserves did not translate to greater charity care across the nation’s nonprofit hospitals, according to a study published this week in Health Affairs.

Hospitals 115

Hospitals 115

STAT

JUNE 7, 2023

WASHINGTON — Republicans aren’t impressed with the Centers for Disease Control and Prevention’s reorganization plan, or its efforts to explain it. The embattled public health agency late Tuesday sent answers to a set of GOP lawmakers’ questions on its “Moving Forward” reform, announced last spring amid building criticism of its Covid-19 response.

112

112

Fierce Healthcare

JUNE 7, 2023

SCAN Group and CareOregon have issued grants to RIP Medical Debt that will wipe out millions in patients' medical debt. | SCAN Group and CareOregon have issued grants to RIP Medical Debt that will wipe out millions in patients' medical debt.

107

107

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management Software

STAT

JUNE 7, 2023

Google will embed its generative AI technology into computer systems at Mayo Clinic and other health systems to make it easier to search vast repositories of patient data and automate administrative tasks, the organizations said Wednesday. The technology is designed to function like a super-charged Google search for health records, allowing hospitals to find and link information about patients to improve care and research.

Mayo Clinic 106

Mayo Clinic HIPAA Hospitals 106

Pharmaceutical Technology

JUNE 7, 2023

AstraZeneca has announced it would stop Andexxa’s Phase IV trial after the study achieved its aims earlier than expected. The ANNEXA-I study (NCT03661528) was designed to assess the use of Andexxa (adexanet alfa) in patients on an oral Factor Xa (FXa) inhibitor treatment including Eliquis (apixaban), which is marketed in the US by Pfizer and Bristol Myers Squibb , and Janssen’s Xarelto (rivaroxaban), who were experiencing an intracranial haemorrhage.

Labelling 105

Labelling Communication 105

pharmaphorum

JUNE 7, 2023

UK pharma struggling to recruit digital talent, says ABPI Phil.

105

105

Drug Store News

JUNE 7, 2023

The gummies contain vitamin D3 for immunity, vitamin K1 for bone health and vitamin B12 to support energy and metabolism.

Immunization 105

Immunization 105

Fierce Healthcare

JUNE 7, 2023

Six-year-old Cityblock Health, a startup that has raised nearly $900 million to date, has restructured its business as it focuses on ramping up payer partnerships and accelerating its path to profi | Six-year-old Cityblock Health, a startup that has raised nearly $900 million to date, has restructured its business as it focuses on ramping up payer partnerships and accelerating its path to profitability.

105

105

Drug Store News

JUNE 7, 2023

The survey also reveals ongoing drug shortages and staffing challenges.

105

105

STAT

JUNE 7, 2023

BOSTON — GSK has been developing vaccines under one corporate guise or another for 140 years, ever since a rural Pennsylvania doctor started pumping smallpox shots out of a converted chicken house in 1882, but the company may be most known today for the vaccine it didn’t build. The British pharma elected not to develop its own Covid shot.

Vaccines 101

Vaccines 101

Fierce Pharma

JUNE 7, 2023

As Alzheimer's disease partners Eisai and Biogen lay the groundwork for a wider launch of Leqembi, their efforts center on winning a full FDA approval. | As Alzheimer's partners Eisai and Biogen lay the groundwork for a wider launch of Leqembi, their efforts center on winning a full FDA approval. On Wednesday, that vision came into better focus as the FDA released a document showing how the agency views the drug.

Documentation 100

Documentation FDA 100

STAT

JUNE 7, 2023

WASHINGTON — Sen. Bill Cassidy (R-La.) is looking into ways to speed up the Food and Drug Administration’s process for reviewing new drugs. “We’re at the reallllly early stages, like ‘can we talk about it?’ sort of thing,” the ranking Senate health committee Republican said about his potential interest in putting a stop to the FDA’s tactic for extending drug review deadlines.

FDA 98

FDA 98

Drug Store News

JUNE 7, 2023

Meraki is making waves in the beauty space with its hair care products, which are infused with crystals to provide additional benefits.

98

98

The Checkup by Singlecare

JUNE 7, 2023

People have consumed vinegar for thousands of years. This potent, fermented liquid takes center stage in sauces, salad dressings, and marinades. Apple cider vinegar (ACV) is a type of vinegar that has gotten a lot of buzz over the last few years. Many wellness writers and influencers claim numerous apple cider vinegar benefits for men (and women). They say it’s a cure for everything from weight loss to erectile dysfunction.

Documentation 98

Documentation Compounding 98

STAT

JUNE 7, 2023

CHICAGO — As a busy weekend at the American Society of Clinical Oncology annual meeting wound down, Lynn Schuchter accepted a gavel from Eric P. Winer, cueing the start of her one-year term as the society’s president. Come Monday, the first official day of her presidency, Schuchter was looking ahead to her year as president. She was also still energized from the plenary session the day before — which Schuchter said was one of the best she’d ever seen.

98

98

Pharmaceutical Technology

JUNE 7, 2023

Eli Lilly has achieved significant gains in the past quarter, leading to it becoming the most valuable pharmaceutical company in the world, with a market cap of $420bn, surpassing Johnson & Johnson. The recent rallying of Lilly’s market value has come as the result of two major announcements: its blockbuster type 2 diabetes (T2D) drug Mounjaro (tirzepatide) successfully completed its second final-stage trial for obesity, and its experimental treatment for Alzheimer’s disease completed its Ph

Pharmaceutical Companies 98

Pharmaceutical Companies Pharmaceutical Companies Labelling FDA 98

STAT

JUNE 7, 2023

In the new book “If I Betray These Words,” I tell the story, with Simon Talbot, of Rita Gallardo (a pseudonym): Deployed in the desert Middle East, confined to a military base ringed by Hesco barriers and razor wire, Dr. Rita Gallardo’s only escape from the horrors of the combat-shattered bodies of young service members was dreaming of the life she might build later.

Hospitals 98

Hospitals 98

European Pharmaceutical Review

JUNE 7, 2023

As its first facility in Scotland, the Cell and Gene Therapy Catapult (CGT Catapult) has opened new laboratories located in the Edinburgh BioQuarter, at the University of Edinburgh’s Institute of Regeneration and Repair. With its new 350m 2 high-specification laboratory space, CGT Catapult aims to provide expertise, resources and technology to help cell therapy developers improve their manufacturing processes and navigate the complex regulatory requirements involved in bringing these therapies t

98

98